263257-15-4

Basic information

• Product Name: Tetrahydropyran-4-ylmagnesium chloride, 0.50 M in THF
• Synonyms: Tetrahydropyran-4-ylmagnesium chloride, 0.50 M in THF;Tetrahydropyran-4-ylmagnesium chloride, 0.50 M in 2-MeTHF;Tetrahydropyran-4-ylmagnesium chloride
• CAS NO: 263257-15-4
• Molecular Formula: C₅H₉ClMgO
• Molecular Weight: 144.89
• Mol File: 263257-15-4.mol
• Article Data: 7

Chemical Properties

• Appearance: /
• CAS DataBase Reference: Tetrahydropyran-4-ylmagnesium chloride, 0.50 M in THF(CAS DataBase Reference)
• NIST Chemistry Reference: Tetrahydropyran-4-ylmagnesium chloride, 0.50 M in THF(263257-15-4)
• EPA Substance Registry System: Tetrahydropyran-4-ylmagnesium chloride, 0.50 M in THF(263257-15-4)

Safety Data

• Hazardous Substances Data: 263257-15-4(Hazardous Substances Data)

Upstream product

• 1768-64-5 4-chlorotetrahydro-2H-pyran 
• 106-93-4 ethylene dibromide 
• 1068-55-9 isopropylmagnesium chloride 
• 7439-95-4 magnesium 

Downstream Products

• 949089-07-0 (2-{[(3,5-bis-trifluoromethyl-benzyl)-(2-methyl-2H-tetrazol-5-yl)-amino]-methyl}-4-trifluoromethyl-phenyl)-(tetrahydro-pyran-4-yl)-methanol 
• 639468-72-7 phenyl(tetrahydro-2H-pyran-4-yl)methanone 
• 1431139-70-6 C₂₀H₃₁NO₃ 
• 852237-39-9 [4-(phenylmethyl)morpholin-2-yl](tetrahydro-2H-pyran-4-yl)methanone 
• 852237-41-3 (S)-(4-benzylmorpholin-2-yl)(tetrahydro-2H-pyran-4-yl)methanone 
• 107813-74-1 [4-(quinolin-2-ylmethoxy)-phenyl]-(tetrahydro-pyran-4-yl)-methanol 

Relevant articles and documents

OXYSTEROLS AND METHODS OF USE THEREOF

Compounds are provided according to Formula (A): and pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof; wherein R1, R2, R3, R4, R5, R6, and RG are as defined herein. Compounds of the present invention are contemplated useful for the prevention and treatment of a variety of conditions.

3-PHENOXYMETHYLPYRROLIDINE COMPOUNDS

In one aspect, the invention relates to compounds of formula I: where R1-6 are as defined in the specification, or a pharmaceutically acceptable salt thereof. The compounds of formula I are serotonin and norepinephrine reuptake inhibitors. In a

Dibenzyl Amine Compounds and Derivatives

Dibenzyl amine compounds and derivatives, pharmaceutical compositions containing such compounds and the use of such compounds to elevate certain plasma lipid levels, including high density lipoprotein-cholesterol and to lower certain other plasma lipid levels, such as LDL-cholesterol and triglycerides and accordingly to treat diseases which are exacerbated by low levels of HDL cholesterol and/or high levels of LDL-cholesterol and triglycerides, such as atherosclerosis and cardiovascular diseases in some mammals, including humans.